Needham analyst Michael Matson maintained a Hold rating on Personalis (PSNL - Research Report) today. The company's shares closed yesterday at $2.70.Matson covers the Healthcare sector, focusing on stocks such as Medtronic, NeoGenomics, and Penumbra. According to TipRanks, Matson has an average return of -1.4% and a 42.75% success rate on recommended stocks. Currently, the analyst consensus on Personalis is a Moderate Buy with an average price target of $18.50.See today’s best-performing stocks on TipRanks >>The company has a one-year high of $21.69 and a one-year low of $2.19. Currently, Personalis has an average volume of 401.4K.
https://www.tipranks.com/news/blurbs/needham-remains-a-hold-on-personalis-psnl?utm_source=advfn.com&utm_medium=referral
Personalis (NASDAQ:PSNL)
Historical Stock Chart
From Oct 2023 to Nov 2023 Click Here for more Personalis Charts.
Personalis (NASDAQ:PSNL)
Historical Stock Chart
From Nov 2022 to Nov 2023 Click Here for more Personalis Charts.